Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/13/2023 | 27.04% | Citigroup | → $35 | Initiates Coverage On | → Buy |
09/01/2023 | 27.04% | Needham | → $35 | Initiates Coverage On | → Buy |
08/09/2023 | 1.63% | Goldman Sachs | $20 → $28 | Maintains | Neutral |
08/08/2023 | 1.63% | Goldman Sachs | $20 → $28 | Maintains | Neutral |
08/08/2023 | 16.15% | Benchmark | $28 → $32 | Maintains | Buy |
08/08/2023 | 1.63% | Barclays | $25 → $28 | Maintains | Equal-Weight |
08/03/2023 | 19.78% | Oppenheimer | $25 → $33 | Maintains | Outperform |
07/20/2023 | -9.26% | Barclays | $20 → $25 | Maintains | Equal-Weight |
05/26/2023 | 1.63% | Benchmark | → $28 | Reiterates | Buy → Buy |
05/18/2023 | -9.26% | Oppenheimer | → $25 | Reiterates | Outperform → Outperform |
05/09/2023 | 1.63% | Benchmark | $26 → $28 | Maintains | Buy |
05/09/2023 | 16.15% | Northland Capital Markets | $30 → $32 | Maintains | Outperform |
01/23/2023 | -27.4% | Barclays | $19 → $20 | Downgrades | Overweight → Equal-Weight |
01/13/2023 | -16.52% | Benchmark | $25 → $23 | Maintains | Buy |
11/09/2022 | -34.66% | Goldman Sachs | $24 → $18 | Maintains | Neutral |
11/08/2022 | -31.03% | Barclays | $22 → $19 | Maintains | Overweight |
11/08/2022 | -9.26% | Oppenheimer | $30 → $25 | Maintains | Outperform |
11/01/2022 | 8.89% | Oppenheimer | $35 → $30 | Maintains | Outperform |
10/24/2022 | -20.15% | Barclays | $24 → $22 | Maintains | Overweight |
09/28/2022 | -12.89% | Barclays | $26 → $24 | Maintains | Overweight |
08/09/2022 | -12.89% | Goldman Sachs | $28 → $24 | Maintains | Neutral |
07/25/2022 | -5.63% | Barclays | $32 → $26 | Maintains | Overweight |
05/11/2022 | 1.63% | Goldman Sachs | $32 → $28 | Maintains | Neutral |
01/12/2022 | 1.63% | Goldman Sachs | $25 → $28 | Maintains | Neutral |
01/12/2022 | 37.93% | Oppenheimer | $34 → $38 | Maintains | Outperform |
11/03/2021 | 23.41% | Oppenheimer | $29 → $34 | Maintains | Outperform |
09/13/2021 | -5.63% | Goldman Sachs | $29 → $26 | Downgrades | Buy → Neutral |
05/05/2021 | 16.15% | Northland Capital Markets | $26 → $32 | Maintains | Outperform |
10/28/2020 | -34.66% | Stifel | $17 → $18 | Maintains | Buy |
09/17/2020 | -45.55% | Barclays | → $15 | Initiates Coverage On | → Overweight |
09/16/2020 | -41.92% | Goldman Sachs | $13.5 → $16 | Upgrades | Neutral → Buy |
06/05/2020 | -34.66% | Oppenheimer | → $18 | Initiates Coverage On | → Outperform |
05/08/2020 | -34.66% | Benchmark | $16 → $18 | Maintains | Buy |
03/03/2020 | -34.66% | Stifel | $14 → $18 | Upgrades | Hold → Buy |
05/07/2019 | — | Benchmark | Upgrades | Hold → Buy | |
03/06/2019 | -56.44% | Stifel | → $12 | Downgrades | Buy → Hold |
What is the target price for Veeco Instruments (VECO)?
The latest price target for Veeco Instruments (NASDAQ: VECO) was reported by Citigroup on September 13, 2023. The analyst firm set a price target for $35.00 expecting VECO to rise to within 12 months (a possible 27.04% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Veeco Instruments (VECO)?
The latest analyst rating for Veeco Instruments (NASDAQ: VECO) was provided by Citigroup, and Veeco Instruments initiated their buy rating.
When is the next analyst rating going to be posted or updated for Veeco Instruments (VECO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Veeco Instruments, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Veeco Instruments was filed on September 13, 2023 so you should expect the next rating to be made available sometime around September 13, 2024.
Is the Analyst Rating Veeco Instruments (VECO) correct?
While ratings are subjective and will change, the latest Veeco Instruments (VECO) rating was a initiated with a price target of $0.00 to $35.00. The current price Veeco Instruments (VECO) is trading at is $27.55, which is within the analyst's predicted range.